Skip to main content
. 2023 Apr 6;13:989466. doi: 10.3389/fonc.2023.989466

Figure 3.

Figure 3

Controlled LN after LN-SIB. Case of a patient receiving a LN-SIB to a remaining sLN in Level I. FDG-PET/CT imaging after 36 months shows regression without signs of recurrence within the lymphatic drainage system. *Dose 58.8 Gy in 28 Fx.